Submitted:
29 September 2024
Posted:
30 September 2024
You are already at the latest version
Abstract
Keywords:
Introduction:
Methodology
Type of Research
Data Collection and Analysis
Tools and Materials
Mitigation of Research Biases
Rationale for Selected Methods
Research Design
Data Collection
Data Analysis
Tools and Materials
Mitigation of Research Biases
Rationale for Method Selection
Quantitative Data Collection
Data Collection Procedure
Qualitative Data Collection
Quantitative Data Analysis
Qualitative Data Analysis
Integration of Quantitative and Qualitative Data
Tools and Materials:
Mitigation of Research Biases
Rationale for Selecting Methods
Results
- -
- 83% of individuals living with HIV reported challenges in accessing dermatological care.
- -
- 72% expressed concerns regarding the efficacy of existing skincare treatments.
- -
- Statistical tests revealed a significant association between the duration of HIV diagnosis and the reported challenges in obtaining skincare treatments (p < 0.05).
- -
- Preferences for Personalized Skincare Solutions:
- -
- 91% of participants preferred personalized skincare solutions tailored to their specific skin sensitivities.
- -
- 67% expressed a preference for non-pharmacological interventions in skincare.
- -
- Access to Dermatological Care:
- -
- Only 41% of individuals living with HIV had received personalized skincare recommendations from healthcare professionals.
- -
- A notable association was found between socioeconomic status and access to specialized dermatological care (p < 0.01).
- -
- Key Secondary Findings:
- -
- Subgroup analysis indicated that participants who had been diagnosed with HIV for more than 10 years were more likely to report challenges in accessing dermatological care compared to those with a recent diagnosis (p < 0.01).
- -
- Secondary outcomes revealed a positive correlation between the frequency of dermatological consultations and the reported satisfaction with skincare treatments (r = 0.73, p < 0.001).
- -
- Hypothesis Confirmation:
- -
- The hypothesis that individuals living with HIV face challenges in accessing dermatological care was supported by the findings.
- -
- The hypothesis that personalized skincare solutions are preferred by individuals living with HIV was strongly supported by the data.
Gaps and Limitations in the Existing Literature
Analysis of Current Skincare Solutions
Exploration of Personalized Skincare Approaches
Psychological and Social Dimensions of mv Skincare
Conclusion
Recommendations for Future Research and Development
- Longitudinal Studies: Future research should focus on longitudinal studies to assess the long-term effectiveness of personalized skincare solutions for individuals living with HIV.
- Integration ofNanomaterials in Skincare: Research and development are needed to integrate nanomaterials in skincare for individuals with HIV to explore innovative and effective skincare interventions.
- Research efforts should focus on understanding the psychological and social dimensions of skincare for individuals living with HIV in order to develop holistic and comprehensive dermatological care approaches.
-
Innovative Interventions: Exploring innovative interventions that integrate dermatological care and social support for individuals living with HIV could enhance the overallwell-being and skincare outcomes for this population.
- Comparative Studies: Comparative studies evaluating the efficacy of existing skincare treatments for individuals living with HIV could provide valuable insights into optimizing dermatological care and treatment strategies.
Discussion
Enhancing Dermatological Care for Individuals Living with HIV: Insights and Future Directions
Interpretation of Findings
Comparison with Literature
Implications
Limitations
Future Work
Appendix A: Research Survey Questions
- What are the most common skincare concerns faced by individuals living with HIV?
- How do socioeconomic factors impact access to skincare treatments for HIV-positive individuals?
- In your experience, what are the major challenges in delivering personalized skincare solutions to this population?
- Can you provide examples of effective self-management strategies for maintaining skin health among individuals living with HIV?
- How do antiretroviral medications affect the dermatological health of HIV-positive individuals?
- What are the psychological and social dimensions that should be considered in skincare solutions for people living with HIV?
- What role do stigma and discrimination play in hindering access to optimal skincare treatments for individuals with HIV?
- In your opinion, what are the key areas where further research on skincare for individuals living with HIV is needed?
- What are the potential benefits of integrating nanomaterials in skincare formulations for this population?
- How can the healthcare system be improved to better address the dermatological care needs of HIV-positive individuals?
References
- Pandey, A. S., Bawiskar, D., & Wagh, V. (2024). Nanocosmetics and Skin Health: A Comprehensive Review of Nanomaterials in Cosmetic Formulations. Cureus, 16(1), e52754. [CrossRef]
- Kumbale, C. M., & Voit, E. 0. (2021). Toward Personalized Medicine for HIV/AIDS. Journal of AIDS and HIV treatment, 3(2), 37-41. [CrossRef]
- Kolimi, P., Narala, S., Nyavanandi, D., Youssef, A. A. A., & Dudhipala, N. (2022). Innovative Treatment Strategies to Accelerate Wound Healing: Trajectory and Recent Advancements. Cells, II (15), 2439. [CrossRef]
- Park, G. H., Nam, C., Hong, S., Park, B., Kim, H., Lee, T., Kim, K., Lee, J. H., & Kim, M. H. (2018). Socioeconomic factors influencing cosmetic usage patterns. Journal of exposure science & environmental epidemiology, 28(3), 242-250. [CrossRef]
- Bouabida, K., Chaves, B. G., & Anane, E. (2023). Challenges and barriers to HIV care engagement and care cascade: viewpoint. Frontiers in reproductive health, 5, 1201087. [CrossRef]
- Silva, E. D., Andrade, L. D., Araujo, P. S., Silveira, V. M., Padilha, C. E., Silva, M.A., & Medeiros, Z. M. (2013). Case study of a patient with HIV-AIDS and visceral leishmaniasis co-infection in multiple episodes. Revista do Instituto de Medicina Tropical de Sao Paulo, 55(6), 425-428. [CrossRef]
- Coates, S. J., & Leslie, K. S. (2019). What's new in HIV dermatology?. FJ000Research, 8, Fl000 Faculty Rev-980. [CrossRef]
- CDC (n.d.). Effectiveness of Prevention Strategies to Reduce the Risk of Acquiring or Transmitting HIV. CDC. https://www.cdc.gov/hiv/risk/estimates/preventionstrategies.html.
- Fisher, C. B., Bragard, E., & Bloom, R. (2020). Ethical Considerations in HIV eHealth Intervention Research: Implications for Informational Risk in Recruitment, Data Maintenance, and Consent Procedures. Current HIV/AIDS reports, 17(3), 180-189. [CrossRef]
- Vitsupakom, S., Pierce, N., & Ritchwood, T. D. (2023). Cultural interventions addressing disparities in the HIV prevention and treatment cascade among Black/African Americans: a scoping review. BMC public health, 23(1), 1748. [CrossRef]
- Weiss, S. M., Tobin, J. N., Antoni, M., Ironson, G., Ishii, M., Vaughn, A., Cassells, A., Jones, D., Schneiderman, N., Brondolo, E., Laperriere, A., Lopez, M., Villar-Loubet, 0., Camille, J., Kumar, M., Page, J. B., & SMART/EST Women's Project Team* (2011). Enhancing the health of women living with HIV: the SMART/EST Women's Project. International journal of women's health, 3, 63-77. [CrossRef]
- Gupta, V., Mohapatra, S., Mishra, H., Farooq, U., Kumar, K., Ansari, M. J., Aldawsari, M. F., Alalaiwe, A. S., Mirza, M. A., & Iqbal, Z. (2022). Nanotechnology in Cosmetics and Cosmeceuticals-A Review of Latest Advancements. Gels (Basel, Switzerland), 8(3), 173. [CrossRef]
- Bouabida, K., Chaves, B. G., & Anane, E. (2023). Challenges and barriers to HIV care engagement and care cascade: viewpoint. Frontiers in reproductive health, 5, 1201087. [CrossRef]
- Litman T. (2019). Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases. APMIS: acta pathologica, microbiologica, et immunologica Scandinavica, 127(5), 386-424. [CrossRef]
- HIV.gov (2024, August 15). U.S. Statistics. HIV.gov. htms://www.hiv.gov/hiv-basics/overview/data-and-trends/statistics Wozna, J., Stypka, J., Baloniak, A., & Zaba, R. (2024). Teledermatology in the diagnosis and treatment of sexually transmitted infections: a narrative review. Postepy dermatologii i alergologii, 41(1), 1-8. [CrossRef]
- Alexoudi, I., Katsarou, A., Paparizos, V., Oikonomou, K., Kourkounti, S., Augerinou, G., & Antoniou, C. (2018). Dermatological conditions associated with HIV medication in a cohort of Greek patients initiating antiretroviral therapy: 1988-2013. Journal of virus eradication, 4(1), 26-29. https://www.ncbi.nhn.nih.gov/pmc/artic1es/PMC585 l l8 l/.
- Krebs, E., Zang, X., Enns, B., Min, J. E., Behrends, C. N., Del Rio, C., Dombrowski, J. C., Feaster, D. J., Gebo, K. A., Golden, M., Marshall, B. D. L., Metsch, L. R., Schackman, B. R., Shoptaw, S., Strathdee, S. A., Nosyk, B., & Localized Economic Modeling Study Group (2020). The impact of localized implementation: determining the cost-effectiveness of HIV prevention and care interventions across six United States cities. AIDS (London, England), 34(3), 447-458. [CrossRef]
- Iliyasu, Z., Haladu, Z. A., Iliyasu, B. Z., Kwaku, A. A., Nass, N. S., Amole, T. G., Abdullahi, H. M., Abdullahi, A. U., Tsiga-Ahmed, F. I., Abdullahi, A., Bashir, H. A., Salihu, H. M., & Aliyu, M. H. (2024). A Qualitative Study of HIV Testing Experiences and HIV Self-Testing Perspectives among Men in Northern Nigeria. Nursing research and practice, 2024, 8810141. [CrossRef]
- NIH (2022, July 28). Addressing HIV-related Intersectional Stigma and Discrimination. National Institute of Mental Health. htu,s://www.nimh.nih.gov/about/director/messages/2022/addressing-hiv-related-intersectional-stigma-and-discrimination.
- Dadi, T. L., Tegene, Y., Vollebregt, N., Medhin, G., & Spigt, M. (2024). The importance of self-management for better treatment outcomes for HIV patients in a low-income setting: perspectives of HIV experts and service providers. AIDS research and therapy, 21(1), 28. htu,s://doi.org/10.1186/s12981-024-00612-9.
- Gheonea, T. C., Oancea, C. N., Mititelu, M., Lupu, E. C., Ionita-Mindrican, C. B., & Rogoveanu, I. (2023). Nutrition and Mental Well-Being: Exploring Connections and Holistic Approaches. Journal of clinical medicine, 12(22), 7180. htu,s://doi.org/10.3390/jcm12227180.
- CDC (n.d.). HIV Cost-effectiveness. U.S. Centers For Disease and Control And Prevention. htu,s://www.cdc.gov/hiv/programresources/guidance/costeffectiveness/index.html.
- Alexoudi, I., Katsarou, A., Paparizos, V., Oikonomou, K., Kourkounti, S., Augerinou, G., & Antoniou, C. (2018). Dermatological conditions associated with HIV medication in a cohort of Greek patients initiating antiretroviral therapy: 1988-2013. Journal of virus eradication, 4(1), 26-29. https://www.ncbi.nhn.nih.gov/pmc/artic1es/PMC585 l l8 l/.
- S, F. A., Madhu, M., Udaya Kumar, V., Dhingra, S., Kumar, N., Singh, S., Ravichandiran, V., & Murti, K. (2022). Nutritional Aspects of People Living with HIV (PLHIV) Amidst COVID-19 Pandemic: an Insight. Current pharmacology reports, 8(5), 350-364. [CrossRef]
- Tripathi, R., Knusel, K. D., Ezaldein, H. H., Scott, J. F., & Bordeaux, J. S. (2018). Association of Demographic and Socioeconomic Characteristics With Differences in Use of Outpatient Dermatology Services in the United States. JAMA dermatology, 154(11), 1286-1291. [CrossRef]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).